Business Development & Innovation Manager | Personalized Liquid Biopsy | Democratizing Healthcare | Biotech Entrepreneur/Consultant
Leuven, België
Joined October 2014
- Tweets1.1K
- Following821
- Followers522
- Likes1.6K
Pinned Tweet
🎉! Hiring Alert 2023! 🎉
🛎 It's an exciting time to join the @NonacusLtd team! We are rapidly growing 🚀 and need more colleagues to help us achieve our global expansion 🌍 !
Go check our open positions here: bit.ly/3iZsCLU
Gregory Maes retweeted
Great EACR Liquid Biopsies 2024 meeting - @GregBioGenomics
@EACRnews
oncodaily.com/url/207040
#Cancer #LiquidBiopsy #CancerResearch #PrecisionMedicine #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology
Gregory Maes retweeted
Bladder cancer educational factsheets - @GregBioGenomics
@WorldBladderCan
oncodaily.com/blog/206746
#Cancer #OncoDaily #Oncology #BladderCancer #MedEd #MedX #MedNews #Medicine
Gregory Maes retweeted
Liquid biopsy for non-invasive cancer detection - @GregBioGenomics
oncodaily.com/url/205189
#Cancer #LiquidBiopsy #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology
Bupa launches first genetic test for bladder cancer for policyholders covermagazine.co.uk/4142870/ via @cover_mag
Gregory Maes retweeted
This #bloodcancerawarenessmonth we want to highlight the realities for patients in the U.K and the importance of streamlining testing. Click the link to find out how Nonacus is collaborating with a leading genomics testing hub to tackle these issues:
bit.ly/3qNDCjX
Gregory Maes retweeted
Introducing a special Lunch & Learn with customer success story by Professor Tim Aitman on the use of Nonacus Custom Panels
-Weds 13th Sept
-1:10-3:00 PM
-University of Edinburgh, Institute of Genetics and Cancer, S1.14 Room
Please RSVP to [email protected]
Gregory Maes retweeted
What makes an ideal MRD marker for Acute Myeloid Leukemia? Features include:
✓ Exclusively present within the AML-defining clone
✓ Absent (or nearly absent) in the preleukemic state
✓ Correlates with therapeutic response
✓ Recurs at disease relapse
bit.ly/3ONmOl2
Gregory Maes retweeted
@eshgsociety is in full party mode! Enjoy the night everyone #eshg2023. See you tomorrow for more #Genetics...
Gregory Maes retweeted
Transitioning single-cell genomics into the clinic go.nature.com/3oHN0EG #Perspective by @drjenlim, @chin_venessa, @FairfaxKirsten, @Moutinho_C, Dan Suan, Hanlee Ji & @drjosephpowell @GarvanInstitute @CellularFutures @kinghorncancer @UNSW @UTAS_ @StanfordMed @Stanford
Gregory Maes retweeted
🎉 Exciting News! Yesterday marked a significant milestone for us with the official opening of our new Birmingham HQ. We were delighted to have the distinguished presence of Angela Douglas MBE, Deputy Chief Scientific Officer for NHS England, leading the ribbon-cutting ceremony.
Gregory Maes retweeted
In our latest blog post we explore the subject of targeted NGS and explain the steps involved in a targeted NGS assay, as well as covering why targeted NGS is necessary for cell-free DNA (cfDNA) samples.
bit.ly/40WPcFU
Great new paper on Bladder Cancer and use of ut/ctDNA for earlier detection, stratification & surveillance. This is exactly the application of @NonacusLtd new Bladder Cancer test. Lear all about it here: galeasbladder.com/galeas-bla…
@NatureRevUrol current and future use of utDNA & ctDNA to improve diagnosis, risk stratification, monitoring, and surveillance 🎯 🚨@OncoAlert
🤓Read the full review here👇
nature.com/articles/s41585-0…
#MedicalOncology #Genomics #PrecisionMedicine #liquidbiopsy
Gregory Maes retweeted
Hello from EACR Molecular Pathology. If you are attending, make sure to drop by our stand to learn about our molecular diagnostic solutions.We will also be showing a poster tomorrow (13:25 – 14:55 in the Main Hall) presented by Nonacus Senior Research Scientist Dr James Hassall.
Gregory Maes retweeted
In our latest blog post, we share five tops tips for getting the most out of the Panel Design Tool and ensuring perfect panel design every time. Click the link below to read on:
bit.ly/3LmfD2X
Gregory Maes retweeted
Our marketing team is rapidly expanding and hiring for several exciting new roles. We are looking for a website manager and digital marketing specialist: to learn more about these roles click the link below:
bit.ly/40rm8Gj
#jobsinscience
Gregory Maes retweeted
Our team are dedicated to improving patient care: by listening to each other and our customers, clear communication and being open minded, we create solutions that will ensure we deliver on our mission.
#liquidbiopsy #moleculardiagnostics #oncology #cancercare
Gregory Maes retweeted
We had great interest at #EAU23 in our innovative Bladder Cancer genetic test to enable early molecular triaging after hematuria! Lear all about it here: galeasbladder.com/galeas-bla…
NEWS ANNOUNCEMENT- Nonacus launches GALEAS® Bladder, a novel test for the non-invasive detection of bladder cancer:
Read the full press release below:
bit.ly/3l0kRH7
We had great interest at #EAU23 in our innovative Bladder Cancer genetic test to enable early molecular triaging after hematuria! Lear all about it here: galeasbladder.com/galeas-bla…
NEWS ANNOUNCEMENT- Nonacus launches GALEAS® Bladder, a novel test for the non-invasive detection of bladder cancer:
Read the full press release below:
bit.ly/3l0kRH7
Gregory Maes retweeted
Interested in learning more about the research behind GALEAS® Bladder? If you are attending the EAU annual meeting, our co-developer Professor Richard Bryan will be at the Nonacus booth today (A65) between 1:30 and 3pm.
bit.ly/3yrxluj
#EAU23
